Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 28 | 2025 | 65 | 7.920 |
Why?
|
| alpha-Synuclein | 16 | 2025 | 21 | 4.710 |
Why?
|
| Disease Models, Animal | 17 | 2017 | 167 | 2.450 |
Why?
|
| Animals | 39 | 2017 | 978 | 2.140 |
Why?
|
| Dopaminergic Neurons | 6 | 2017 | 6 | 1.760 |
Why?
|
| Neurons | 14 | 2017 | 55 | 1.760 |
Why?
|
| Brain | 8 | 2017 | 197 | 1.500 |
Why?
|
| Nerve Degeneration | 5 | 2017 | 8 | 1.430 |
Why?
|
| Multiple System Atrophy | 4 | 2025 | 4 | 1.380 |
Why?
|
| Humans | 36 | 2025 | 2822 | 1.380 |
Why?
|
| Genetic Therapy | 6 | 2015 | 18 | 1.210 |
Why?
|
| Aging | 8 | 2017 | 190 | 1.180 |
Why?
|
| Huntington Disease | 6 | 2014 | 9 | 1.130 |
Why?
|
| Neurodegenerative Diseases | 5 | 2016 | 32 | 1.080 |
Why?
|
| Antiparkinson Agents | 2 | 2017 | 4 | 1.010 |
Why?
|
| Neuroprotective Agents | 3 | 2013 | 4 | 0.960 |
Why?
|
| Brain Tissue Transplantation | 3 | 2012 | 5 | 0.780 |
Why?
|
| Corpus Striatum | 8 | 2017 | 15 | 0.760 |
Why?
|
| Gene Transfer Techniques | 4 | 2011 | 11 | 0.750 |
Why?
|
| Lewy Bodies | 4 | 2016 | 37 | 0.670 |
Why?
|
| Substantia Nigra | 8 | 2017 | 12 | 0.590 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 16 | 0.560 |
Why?
|
| Cerebral Cortex | 4 | 2012 | 25 | 0.550 |
Why?
|
| Female | 17 | 2025 | 1644 | 0.550 |
Why?
|
| Oligodendroglia | 1 | 2017 | 1 | 0.540 |
Why?
|
| Lewy Body Disease | 2 | 2025 | 13 | 0.540 |
Why?
|
| Cryopreservation | 1 | 2017 | 2 | 0.540 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 2 | 0.540 |
Why?
|
| Primates | 1 | 2017 | 1 | 0.540 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2017 | 1 | 0.530 |
Why?
|
| Levodopa | 1 | 2017 | 4 | 0.530 |
Why?
|
| Male | 18 | 2025 | 1781 | 0.530 |
Why?
|
| Stem Cells | 1 | 2014 | 3 | 0.450 |
Why?
|
| Tissue Extracts | 1 | 2014 | 1 | 0.440 |
Why?
|
| Dopamine | 6 | 2017 | 14 | 0.440 |
Why?
|
| Dependovirus | 6 | 2017 | 11 | 0.430 |
Why?
|
| Cell Transplantation | 2 | 2011 | 2 | 0.430 |
Why?
|
| Colon | 1 | 2013 | 5 | 0.420 |
Why?
|
| Neurturin | 2 | 2015 | 3 | 0.420 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2017 | 161 | 0.400 |
Why?
|
| Antibodies | 1 | 2013 | 16 | 0.390 |
Why?
|
| Macaca mulatta | 9 | 2017 | 11 | 0.390 |
Why?
|
| Transplants | 1 | 2012 | 1 | 0.370 |
Why?
|
| Mice | 9 | 2016 | 305 | 0.370 |
Why?
|
| Rats | 6 | 2017 | 233 | 0.330 |
Why?
|
| Hydrogels | 1 | 2009 | 4 | 0.310 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 2 | 0.310 |
Why?
|
| Neurosciences | 1 | 2009 | 2 | 0.310 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 10 | 0.310 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 17 | 0.310 |
Why?
|
| Motor Activity | 1 | 2008 | 51 | 0.290 |
Why?
|
| Tyrosine 3-Monooxygenase | 5 | 2015 | 9 | 0.280 |
Why?
|
| Genetic Vectors | 4 | 2017 | 11 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 7 | 2015 | 39 | 0.250 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factors | 1 | 2006 | 2 | 0.250 |
Why?
|
| Proteomics | 1 | 2025 | 1 | 0.230 |
Why?
|
| Neurogenesis | 2 | 2017 | 2 | 0.230 |
Why?
|
| History, 20th Century | 3 | 2017 | 5 | 0.210 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 32 | 0.190 |
Why?
|
| Parkinsonian Disorders | 2 | 2015 | 24 | 0.190 |
Why?
|
| Huntingtin Protein | 4 | 2014 | 6 | 0.190 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 23 | 0.180 |
Why?
|
| Mesencephalon | 3 | 2017 | 3 | 0.180 |
Why?
|
| Time Factors | 2 | 2013 | 205 | 0.180 |
Why?
|
| Behavior, Animal | 3 | 2016 | 20 | 0.170 |
Why?
|
| Microglia | 2 | 2017 | 11 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 39 | 0.160 |
Why?
|
| Congresses as Topic | 2 | 2016 | 9 | 0.160 |
Why?
|
| Cell Line | 2 | 2017 | 54 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 80 | 0.150 |
Why?
|
| Mitochondria | 2 | 2016 | 12 | 0.150 |
Why?
|
| Endopeptidase K | 1 | 2017 | 1 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 2 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2017 | 7 | 0.140 |
Why?
|
| Haplorhini | 1 | 2017 | 2 | 0.140 |
Why?
|
| Astrocytes | 1 | 2017 | 10 | 0.130 |
Why?
|
| History, 21st Century | 2 | 2017 | 4 | 0.130 |
Why?
|
| Pyruvic Acid | 1 | 2016 | 1 | 0.130 |
Why?
|
| Autophagy | 1 | 2016 | 5 | 0.130 |
Why?
|
| Middle Aged | 5 | 2025 | 756 | 0.130 |
Why?
|
| Axons | 1 | 2016 | 3 | 0.130 |
Why?
|
| Colon, Sigmoid | 1 | 2016 | 3 | 0.130 |
Why?
|
| Inflammation | 1 | 2016 | 27 | 0.130 |
Why?
|
| Pyridines | 2 | 2016 | 12 | 0.130 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 1 | 0.130 |
Why?
|
| Graft Survival | 3 | 2014 | 10 | 0.120 |
Why?
|
| Disease Progression | 2 | 2013 | 95 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2011 | 35 | 0.120 |
Why?
|
| Ataxin-1 | 1 | 2015 | 1 | 0.120 |
Why?
|
| Cerebellar Nuclei | 1 | 2015 | 1 | 0.120 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2015 | 1 | 0.120 |
Why?
|
| RNA Interference | 1 | 2015 | 4 | 0.120 |
Why?
|
| Aged | 4 | 2025 | 898 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 10 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2015 | 47 | 0.120 |
Why?
|
| Adrenergic Uptake Inhibitors | 2 | 2012 | 2 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2015 | 44 | 0.120 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 2 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 8 | 0.120 |
Why?
|
| Peptides | 1 | 2015 | 19 | 0.110 |
Why?
|
| Immune Tolerance | 1 | 2014 | 1 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 1 | 0.110 |
Why?
|
| Heterografts | 1 | 2014 | 1 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2014 | 4 | 0.110 |
Why?
|
| Polysaccharides | 1 | 2013 | 3 | 0.110 |
Why?
|
| Chromatography, Gas | 1 | 2013 | 4 | 0.110 |
Why?
|
| Vagus Nerve | 1 | 2013 | 5 | 0.110 |
Why?
|
| Permeability | 1 | 2013 | 14 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2013 | 5 | 0.110 |
Why?
|
| Linear Models | 1 | 2013 | 34 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 97 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 68 | 0.100 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2013 | 1 | 0.100 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 6 | 0.100 |
Why?
|
| Pyrazoles | 1 | 2013 | 4 | 0.100 |
Why?
|
| Protein Folding | 1 | 2013 | 2 | 0.100 |
Why?
|
| Protein Engineering | 1 | 2013 | 5 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 15 | 0.100 |
Why?
|
| Morpholines | 1 | 2012 | 1 | 0.100 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2012 | 1 | 0.100 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 9 | 0.100 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 11 | 0.100 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 8 | 0.100 |
Why?
|
| Psychomotor Performance | 2 | 2009 | 29 | 0.100 |
Why?
|
| Neurobiology | 1 | 2012 | 1 | 0.100 |
Why?
|
| Calcium Channels, L-Type | 1 | 2012 | 29 | 0.100 |
Why?
|
| HIV-1 | 1 | 2012 | 59 | 0.090 |
Why?
|
| Gene Expression | 2 | 2010 | 45 | 0.090 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2012 | 1 | 0.090 |
Why?
|
| Mutation | 2 | 2010 | 76 | 0.090 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2012 | 3 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 3 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 1 | 0.090 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2011 | 1 | 0.090 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2011 | 1 | 0.090 |
Why?
|
| Adrenergic Neurons | 1 | 2011 | 1 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 540 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2011 | 8 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 2 | 0.090 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2010 | 1 | 0.080 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 1 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2010 | 4 | 0.080 |
Why?
|
| Amyloid beta-Peptides | 1 | 2010 | 27 | 0.080 |
Why?
|
| Risk Factors | 1 | 2011 | 263 | 0.080 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2010 | 1 | 0.080 |
Why?
|
| Enzyme Therapy | 1 | 2010 | 1 | 0.080 |
Why?
|
| Enzymes | 1 | 2010 | 2 | 0.080 |
Why?
|
| Glutamic Acid | 1 | 2010 | 6 | 0.080 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2009 | 1 | 0.080 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2009 | 1 | 0.080 |
Why?
|
| Quinolinic Acid | 1 | 2009 | 1 | 0.080 |
Why?
|
| Functional Laterality | 1 | 2009 | 5 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 41 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2009 | 10 | 0.080 |
Why?
|
| Environment | 1 | 2009 | 3 | 0.080 |
Why?
|
| Rotarod Performance Test | 1 | 2008 | 3 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 7 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 5 | 0.080 |
Why?
|
| Neuropeptides | 1 | 2008 | 7 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2008 | 5 | 0.080 |
Why?
|
| Random Allocation | 1 | 2008 | 23 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 236 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2014 | 12 | 0.070 |
Why?
|
| Biopsy | 2 | 2016 | 13 | 0.060 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2006 | 2 | 0.060 |
Why?
|
| Inclusion Bodies | 1 | 2006 | 3 | 0.060 |
Why?
|
| Cell Death | 1 | 2006 | 10 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 6 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 25 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2015 | 117 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2016 | 93 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2014 | 3 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2014 | 3 | 0.050 |
Why?
|
| Papio | 2 | 2013 | 3 | 0.050 |
Why?
|
| Cell Survival | 2 | 2011 | 19 | 0.040 |
Why?
|
| Synaptophysin | 2 | 2009 | 4 | 0.040 |
Why?
|
| Age Factors | 2 | 2009 | 84 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2010 | 21 | 0.040 |
Why?
|
| Anniversaries and Special Events | 1 | 2017 | 1 | 0.030 |
Why?
|
| History, 19th Century | 1 | 2017 | 1 | 0.030 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2016 | 1 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 1 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 3 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 4 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 47 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2016 | 9 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2015 | 1 | 0.030 |
Why?
|
| Thalamus | 1 | 2015 | 2 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 3 | 0.030 |
Why?
|
| Brain Stem | 1 | 2015 | 5 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 2015 | 1 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2015 | 4 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 16 | 0.030 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2015 | 5 | 0.030 |
Why?
|
| CCAAT-Binding Factor | 1 | 2015 | 2 | 0.030 |
Why?
|
| Chemokine CCL11 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 6 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 11 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 15 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 33 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2014 | 1 | 0.030 |
Why?
|
| Animals, Outbred Strains | 1 | 2014 | 1 | 0.030 |
Why?
|
| Radioactive Tracers | 1 | 2013 | 1 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2013 | 5 | 0.030 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2012 | 1 | 0.020 |
Why?
|
| Propylamines | 1 | 2012 | 1 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 63 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 110 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 4 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2011 | 3 | 0.020 |
Why?
|
| Microscopy | 1 | 2011 | 5 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 49 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2010 | 1 | 0.020 |
Why?
|
| NADPH Dehydrogenase | 1 | 2010 | 1 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2010 | 1 | 0.020 |
Why?
|
| Silver Staining | 1 | 2010 | 1 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2010 | 1 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 5 | 0.020 |
Why?
|
| Plaque, Amyloid | 1 | 2010 | 19 | 0.020 |
Why?
|
| tau Proteins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Axonal Transport | 1 | 2010 | 1 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 11 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2010 | 11 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2009 | 3 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2009 | 10 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 18 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 48 | 0.020 |
Why?
|
| Lentivirus | 1 | 2009 | 1 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2009 | 3 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 5 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 4 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2009 | 3 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2009 | 12 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2009 | 9 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2009 | 15 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2009 | 60 | 0.020 |
Why?
|
| Hippocampus | 1 | 2009 | 41 | 0.020 |
Why?
|
| Autopsy | 1 | 2009 | 39 | 0.020 |
Why?
|
| Oleanolic Acid | 1 | 2009 | 2 | 0.020 |
Why?
|
| Neocortex | 1 | 2009 | 2 | 0.020 |
Why?
|
| NADP | 1 | 2008 | 1 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2008 | 5 | 0.020 |
Why?
|
| Cats | 1 | 2008 | 6 | 0.020 |
Why?
|
| Child | 1 | 2008 | 190 | 0.020 |
Why?
|
| Adult | 1 | 2008 | 759 | 0.020 |
Why?
|
| Dementia | 1 | 2006 | 68 | 0.010 |
Why?
|